Impact of COVID-19 on patterns of drug use and drug-related harms in Europe
Impact of COVID-19 on patterns of drug use and drug-related harms in Europe
复制标题
COVID-19 对欧洲吸毒模式和毒品相关危害的影响
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Emcdda Trendspotter
中科院分区：
文献类型：
--
作者：
Emcdda Trendspotter
2020 年 4 月 28 日，在捷克全国范围内针对减少伤害、门诊和住院药物服务的客户启动了一项多中心血清行为研究。 5 月 17 日客户检测的初步结果显示，冠状病毒感染率较低（968 名客户中有 5 名 IgG/IgM 快速检测呈阳性）。超过一半的受访者表示，他们的吸毒频率（54%）、吸毒量（59%）以及注射或混合毒品等高风险行为（61%）没有变化。虽然大多数客户报告健康质量指标没有变化，但有报告称财务状况（32％）、心理健康（26％）、整体生活质量（25％）、工作机会（24％）、其他人的态度（22％）和食物供应（14％）恶化。
A multi-centre sero-behavioural study was initiated on 28 April 2020 across Czechia among clients of harm reduction, outpatient and inpatient drug services. Preliminary results from client testing on 17 May reveal a low prevalence of coronavirus infection (5 out of 968 clients with positive IgG/IgM rapid tests). Just over half of respondents reported no change in their frequency of drug use (54 %), the amounts used (59 %) and high-risk behaviours such as injecting or mixing drugs (61 %). While most clients reported no change with regard to health quality indicators, there were reports of deteriorations in financial situation (32 %), mental health (26 %), overall quality of life (25 %), job offers (24 %), attitudes of other people (22 %) and food availability (14 %).